Details
Stereochemistry | ACHIRAL |
Molecular Formula | C16H25N5O2 |
Molecular Weight | 319.402 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCN1C2=C(NC(=N2)C3(N)CCCC3)C(=O)N(CCC)C1=O
InChI
InChIKey=UFOBUCDTKQDDTN-UHFFFAOYSA-N
InChI=1S/C16H25N5O2/c1-3-9-20-12-11(13(22)21(10-4-2)15(20)23)18-14(19-12)16(17)7-5-6-8-16/h3-10,17H2,1-2H3,(H,18,19)
Molecular Formula | C16H25N5O2 |
Molecular Weight | 319.402 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://adisinsight.springer.com/drugs/800006420
Sources: https://adisinsight.springer.com/drugs/800006420
Midaxifylline, a potent and selective xanthine adenosine A1 receptor antagonist, was investigated for the treatment of Alzheimer's disease, cardiovascular disorders, kidney disorders, and major depressive disorder. However, all studies were discontinued.
Originator
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:14:16 GMT 2023
by
admin
on
Fri Dec 15 16:14:16 GMT 2023
|
Record UNII |
A937Z0MS6C
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C744
Created by
admin on Fri Dec 15 16:14:16 GMT 2023 , Edited by admin on Fri Dec 15 16:14:16 GMT 2023
|
||
|
NCI_THESAURUS |
C319
Created by
admin on Fri Dec 15 16:14:16 GMT 2023 , Edited by admin on Fri Dec 15 16:14:16 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
A937Z0MS6C
Created by
admin on Fri Dec 15 16:14:16 GMT 2023 , Edited by admin on Fri Dec 15 16:14:16 GMT 2023
|
PRIMARY | |||
|
151159-23-8
Created by
admin on Fri Dec 15 16:14:16 GMT 2023 , Edited by admin on Fri Dec 15 16:14:16 GMT 2023
|
PRIMARY | |||
|
7641
Created by
admin on Fri Dec 15 16:14:16 GMT 2023 , Edited by admin on Fri Dec 15 16:14:16 GMT 2023
|
PRIMARY | |||
|
3047747
Created by
admin on Fri Dec 15 16:14:16 GMT 2023 , Edited by admin on Fri Dec 15 16:14:16 GMT 2023
|
PRIMARY | |||
|
SUB03288MIG
Created by
admin on Fri Dec 15 16:14:16 GMT 2023 , Edited by admin on Fri Dec 15 16:14:16 GMT 2023
|
PRIMARY | |||
|
100000085962
Created by
admin on Fri Dec 15 16:14:16 GMT 2023 , Edited by admin on Fri Dec 15 16:14:16 GMT 2023
|
PRIMARY | |||
|
CHEMBL2106736
Created by
admin on Fri Dec 15 16:14:16 GMT 2023 , Edited by admin on Fri Dec 15 16:14:16 GMT 2023
|
PRIMARY | |||
|
DTXSID90164721
Created by
admin on Fri Dec 15 16:14:16 GMT 2023 , Edited by admin on Fri Dec 15 16:14:16 GMT 2023
|
PRIMARY | |||
|
C66147
Created by
admin on Fri Dec 15 16:14:16 GMT 2023 , Edited by admin on Fri Dec 15 16:14:16 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|